Patents by Inventor Simon J Foster

Simon J Foster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • polypeptide and antibodies
    Patent number: 9067980
    Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: June 30, 2015
    Assignee: Absynth Biologics Limited
    Inventors: Simon J. Foster, Jorge Garcia-Lara
  • S. AUREUS POLYPEPTIDE AND ANTIBODIES
    Publication number: 20140099314
    Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.
    Type: Application
    Filed: December 10, 2013
    Publication date: April 10, 2014
    Applicant: ABSYNTH BIOLOGICS LIMITED
    Inventors: Simon J. FOSTER, Jorge GARCIA-LARA
  • polypeptides and antibodies
    Patent number: 8632779
    Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.
    Type: Grant
    Filed: March 14, 2012
    Date of Patent: January 21, 2014
    Assignee: Absynth Biologics Limited
    Inventors: Simon J. Foster, Jorge Garcia-Lara
  • POLYPEPTIDES
    Publication number: 20120171214
    Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.
    Type: Application
    Filed: March 14, 2012
    Publication date: July 5, 2012
    Applicant: ABSYNTH BIOLOGICS LIMITED
    Inventors: Simon J. FOSTER, Jorge GARCIA-LARA
  • PheP, an amino acid permease of
    Patent number: 8168204
    Abstract: The present invention relates to antigenic polypeptides expressed by pathogenic microbes, including antigenic polypeptides encoded by the nucleic acid sequence of FIG. 1, vaccines comprising the antigenic polypeptides and therapeutic antibodies directed to the antigenic polypeptides.
    Type: Grant
    Filed: April 23, 2010
    Date of Patent: May 1, 2012
    Assignee: Absynth Biologics Ltd.
    Inventor: Simon J. Foster
  • polypeptides and antibodies
    Patent number: 8163288
    Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.
    Type: Grant
    Filed: June 29, 2010
    Date of Patent: April 24, 2012
    Assignee: Absynth Biologics Limited
    Inventors: Simon J. Foster, Jorge Garcia-Lara
  • PHEP, AN AMINO ACID PERMEASE OF STAPHYLOCOCCUS AUREUS
    Publication number: 20110171237
    Abstract: The present invention relates to antigenic polypeptides expressed by pathogenic microbes, including antigenic polypeptides encoded by the nucleic acid sequence of FIG. 1, vaccines comprising the antigenic polypeptides and therapeutic antibodies directed to the antigenic polypeptides.
    Type: Application
    Filed: April 23, 2010
    Publication date: July 14, 2011
    Applicant: ABSYNTH BIOLOGICS LTD.
    Inventor: Simon J. FOSTER
  • POLYPEPTIDES
    Publication number: 20110091465
    Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.
    Type: Application
    Filed: June 29, 2010
    Publication date: April 21, 2011
    Applicant: ABSYNTH BIOLOGICS LIMITED
    Inventors: Simon J. FOSTER, Jorge GARCIA-LARA
  • polypeptides
    Patent number: 7767211
    Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.
    Type: Grant
    Filed: March 8, 2006
    Date of Patent: August 3, 2010
    Assignee: Absynth Biologics Limted
    Inventors: Simon J. Foster, Jorge Garcia-Lara
  • Phep, an amino acid permease of
    Patent number: 7740869
    Abstract: The present invention relates to antigenic polypeptides expressed by pathogenic microbes, including antigenic polypeptides encoded by the nucleic acid sequence of FIG. 1, vaccines comprising the antigenic polypeptides and therapeutic antibodies directed to the antigenic polypeptides.
    Type: Grant
    Filed: April 8, 2005
    Date of Patent: June 22, 2010
    Assignee: Absynth Biologics Ltd.
    Inventor: Simon J. Foster
  • Polypeptides
    Publication number: 20080311108
    Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.
    Type: Application
    Filed: March 8, 2006
    Publication date: December 18, 2008
    Applicant: ABSYNTH BIOLOGICS LIMITED
    Inventors: Simon J. Foster, Jorge Garcia-Lara
  • Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
    Patent number: 7169903
    Abstract: The present invention encompasses protective monoclonal antibodies that bind to peptidoglycan of Gram-positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and block nasal colonization by Gram-positive bacteria in vivo. The invention also provides human, humanized and chimeric antibodies. The invention also sets forth the heavy chain and light chain variable regions of an antibody within the invention.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: January 30, 2007
    Assignee: Biosynexus Incorporated
    Inventors: Richard F. Schuman, John Fitzgerald Kokai-Kun, Simon J. Foster, Jeffrey R. Stinson, Gerald Walter Fischer
  • Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
    Publication number: 20030228322
    Abstract: The present invention encompasses protective monoclonal antibodies that bind to peptidoglycan of Gram-positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and block nasal colonization by Gram-positive bacteria in vivo. The invention also provides human, humanized and chimeric antibodies. The invention also sets forth the heavy chain and light chain variable regions of an antibody within the invention.
    Type: Application
    Filed: December 20, 2002
    Publication date: December 11, 2003
    Inventors: Richard F. Schuman, John Fitzgerald Kokai-Kun, Simon J. Foster, Jeffrey R. Stinson, Gerald Walter Fischer
  • Novel glucosaminidase
    Publication number: 20020076766
    Abstract: The invention provides glucosaminidase polypeptides and DNA (RNA) encoding glucosaminidase polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing glucosaminidase polypeptides to screen for antibacterial compounds.
    Type: Application
    Filed: January 25, 2001
    Publication date: June 20, 2002
    Inventors: Michael Terence Black, John Edward Hodgson, David Justin Charles Knowles, Raymond Winfield Reichard, Richard O. Nicholas, Martin Karl Russel Burnham, Julie M. Pratt, Martin Rosenberg, Judith M. Ward, Simon J. Foster
  • Novel glucosaminidase
    Publication number: 20010039038
    Abstract: The invention provides glucosaminidase polypeptides and DNA (RNA) encoding glucosaminidase polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing glucosaminidase polypeptides to screen for antibacterial compounds.
    Type: Application
    Filed: January 25, 2001
    Publication date: November 8, 2001
    Inventors: Michael Terence Black, John Edward Hodgson, David Justin Charles Knowles, Raymond Winfield Reichard, Richard O. Nicholas, Martin Karl Russel Burnham, Julie M. Pratt, Martin Rosenberg, Judith M. Ward, Simon J. Foster
  • Glucosaminidase
    Patent number: 6228619
    Abstract: The invention provides glucosaminidase polypeptides and DNA (RNA) encoding glucosaminidase polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing glucosaminidase polypeptides to screen for antibacterial compounds.
    Type: Grant
    Filed: October 9, 1997
    Date of Patent: May 8, 2001
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham plc, University of Sheffield
    Inventors: Simon J Foster, Michael Terence Black, John Edward Hodgson, David Justin Charles Knowles, Raymond Winfield Reichard, Richard O Nicholas, Martin Karl Russel Burnham, Julie M Pratt, Martin Rosenberg, Judith M Ward